COMMUNIQUÉS West-GlobeNewswire

Idorsia initiates a Phase 3 registration program with nemorexant (ACT-541468) for the treatment of insomnia

11/06/2018 - 07:01

Idorsia to host an investor webcast to discuss the Phase 3 program today at 14:00hrs CEST Allschwil, Switzerland - June 11, 2018 Idorsia Ltd (SIX: IDIA) today announced that the first patients have been enrolled into [...]

Innate Pharma to present at the Bryan Garnier 3rd Annual Oncology Day on June 13, 2018

11/06/2018 - 07:01

Innate Pharma to present at the Bryan Garnier 3rd Annual Oncology Day on June 13, 2018 Marseille, France, June 11, 2018, 07:00 AM CEST Innate Pharma (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces [...]

Innate pharma à la 3ème journée Oncologie de Bryan Garnier le 13 juin 2018

11/06/2018 - 07:01

Innate pharma à la 3ème journée Oncologie de Bryan Garnier le 13 juin 2018 Marseille le 11 juin 2018, 7h00 CEST Innate Pharma SA (la « Société » - Euronext Paris : FR0010331421 - IPH) annonce aujourd'hui qu'elle sera [...]

Bone Therapeutics SA : Information on the total number of voting rights and shares

11/06/2018 - 07:01

Regulated information Information on the total number of voting rights and shares Gosselies, Belgium, 11 June 2018, 7am CEST - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company [...]

Bone Therapeutics SA : Information relative au nombre total de droits de vote et d'actions

11/06/2018 - 07:01

Information réglementée Information relative au nombre total de droits de vote et d'actions Gosselies, Belgique, le 11 juin 2018, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de [...]

Resverlogix Announces Withdrawal of Public Offering of Units

09/06/2018 - 00:39

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, June 08, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) [...]

Adamas Announces New Employment Inducement Grant

08/06/2018 - 23:55

EMERYVILLE, Calif., June 08, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the compensation committee of the company’s board of directors granted six new employees the option [...]

Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

08/06/2018 - 22:01

MENLO PARK, Calif., June 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]

Tetraphase Pharmaceuticals Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

08/06/2018 - 22:01

WATERTOWN, Mass., June 08, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]

Cytokinetics Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy to be Presented at the 2018 Annual Cure SMA Conference on June 16, 2018

08/06/2018 - 22:00

SOUTH SAN FRANCISCO, Calif., June 08, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that data from the Phase 2 clinical study of reldesemtiv in patients with spinal muscular atrophy ( [...]

AxoGen Chairman and CEO Karen Zaderej Named Entrepreneur Of The Year 2018 Award Winner in Florida

08/06/2018 - 17:50

Award recognizes entrepreneurs who are excelling in areas such as innovation, financial performance, and personal commitment to their businesses and communities ALACHUA, Fla., June 08, 2018 (GLOBE NEWSWIRE) -- AxoGen, [...]

Positive clinical phase III results of vortioxetine in Japanese adults with Major Depressive Disorder

08/06/2018 - 17:24

New clinical phase III data from a study conducted in Japan demonstrate the efficacy of vortioxetine compared to placebo for the treatment of Major Depressive Disorder (MDD) in Japanese adults Positive results suggest [...]

CALSTAR Air Medical Services to Open New Air Medical Base in Santa Cruz County

08/06/2018 - 17:00

SANTA CRUZ, Calif., June 08, 2018 (GLOBE NEWSWIRE) -- CALSTAR Air Medical Services, a subsidiary of REACH Air Medical Holdings, has announced that it will open a new air medical transport base in Santa Cruz County [...]

Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the 41st European Cystic Fibrosis Conference (ECFS)

08/06/2018 - 17:00

ELX-02 demonstrated dose-dependent rescue of CFTR function in human bronchial epithelial cells (HBEs) and organoids from patients carrying at least one nonsense CFTR mutation Eloxx expects to initiate a Phase 2 clinical [...]

Solon Eiendom ASA : Preliminary result of the subsequent offering

08/06/2018 - 16:49

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]

Cannabis Wheaton Income Corp. Announces Name Change to Auxly Cannabis Group Inc.

08/06/2018 - 16:45

VANCOUVER, British Columbia, June 08, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) (" Auxly " or the " Company ") is pleased to announce that it has changed its corporate name from “Cannabis Wheaton [...]

NHL player Max Domi teams up with thousands of Torontonians to walk to find a cure for type 1 diabetes

08/06/2018 - 16:03

The Sun Life Walk to Cure Diabetes for JDRF aims to raise $5.4M to accelerate research TORONTO, June 08, 2018 (GLOBE NEWSWIRE) -- NHL player, Max Domi will be walking at the Sun Life Walk to Cure Diabetes for JDRF’s [...]

Oncobiologics Closes Second Tranche of $15 Million Private Placement

08/06/2018 - 15:15

CRANBURY, N.J., June 08, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (the “Company”) today announced that it has closed on the second, and final, tranche of a $15.0 million private placement of shares of [...]

ADMA Biologics Announces Pricing of Public Offering of Common Stock

08/06/2018 - 15:08

RAMSEY, N.J. and BOCA RATON, Fla., June 08, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) (“ADMA” or the “Company”) announced today the pricing of its previously announced underwritten public offering of 8 [...]